EFDID: 257125EFD: View Filing

Issuer: INNOVATE BIOPHARMACEUTICALS, INC. (0001551986) - D

Accession: 0001666690-18-000005 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001551986
  • Entity Name:
    INNOVATE BIOPHARMACEUTICALS, INC.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    8480 Honeycutt Road
    Suite 120
    Raleigh, NC 27615
  • Persons:
    Related Persons 7
    Jay Madan
    Executive Officer, Director
    Sandeep Laumas
    Executive Officer, Director
    Christopher Prior
    Executive Officer, Director
    Roy Proujansky
    Director
    Lorin Johnson
    Director
    Anthony Maida
    Director
    Anna Kazanchyan
    Director
EDGAR: Offering Information
  • Accession Date:
    02/12/2018
  • First Sale Date:
    01/29/2018
  • Offering Amount:
    $92,751,768
  • Amount Sold:
    $92,751,768
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
  • Sales Clarification:
    Total Offering Amount represents the aggregate offering amount of common shares and warrants to purchase common stock issued pursuant to a merger agreement.
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:AL, CA, MD, NC, NJ, PA, TX, WI
Inactive:CO, GA, IL, MS, NV, OH, TN
EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
INNOVATE BIOPHARMACEUTICALS, INC./s/ Jay MadanJay MadanPresident2018-02-12